Cargando…
What does complement do in Alzheimer’s disease? Old molecules with new insights
Increasing evidence suggests that inflammatory and immune components in brain are important in Alzheimer’s disease (AD) and anti-inflammatory and immunotherapeutic approaches may be amenable to AD treatment. It is known that complement activation occurs in the brain of patients with AD, and contribu...
Autores principales: | Shen, Yong, Yang, Libang, Li, Rena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853043/ https://www.ncbi.nlm.nih.gov/pubmed/24119446 http://dx.doi.org/10.1186/2047-9158-2-21 |
Ejemplares similares
-
What do we know from clinical trials on exercise and Alzheimer's disease?
por: Shen, Yong, et al.
Publicado: (2016) -
Complement and autoimmunity: new insights into old questions
por: Holers, VM, et al.
Publicado: (2004) -
Genetic Insights into the Impact of Complement in Alzheimer’s Disease
por: Torvell, Megan, et al.
Publicado: (2021) -
Disruption of specific GDNF receptor subtype signaling impairs cortical neuronal survival in Alzheimer’s brains
por: Konishi, Yoshihiro, et al.
Publicado: (2012) -
Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
por: Elhassan, Yasir S., et al.
Publicado: (2017)